Skip to main content
Acta Veterinaria Scandinavica logoLink to Acta Veterinaria Scandinavica
. 1999 Jun 1;40(2):145–150. doi: 10.1186/BF03547031

Local Tissue Damage in Cows after Intramuscular Administration of Preparations Containing Phenylbutazone, Flunixin, Ketoprofen and Metamizole

Lokal vävnadsirritation i kor efter intramuskulära injektioner med fenylbutazon, flunixin, Ketoprofen, och metamizol

S Pyörälä 1,, T Laurila 1, S Lehtonen 1, S Leppä 1, L Kaartinen 2
PMCID: PMC8043161  PMID: 10605130

Abstract

Tissue irritation after intramuscular injections of 4 nonsteroidal anti-inflammatory agents was studied in 5 lactating cows. Preparations containing phenylbutazone, flunixin, metamizole (dipyrone) and ketoprofen were investigated; physiological saline was used as a control substance. Tissue reactions at the injection sites were examined by palpation and by determining serum creatine kinase. A kinetic method based on creatine kinase released from the injured muscle tissue was used, which allowed estimation of the amount of damaged muscle. The metamizole preparation clearly provoked signs of pain in all the cows. After flunixin and phenylbutazone injections slight reactions were observed, and ketoprofen and saline did not cause any clinical signs. Some palpatory findings after injections were found for all the preparations except saline. Based on serum creatine kinase, the 2 most irritating preparations were the ones containing flunixin and phenylbutazone. After injections of these 2 substances, the estimated amount of damaged muscle was about 80 grams. The statistical difference between flunixin and phenylbutazone and the other 2 preparations was significant. Physiological saline had no effect on serum creatine kinase. For preparations containing phenylbutazone and flunixin, intravenous administration is recommended.

Keywords: bovine, creatine kinase, nonsteroidal anti-inflammatory agents, muscle damage, local tolerance

Full Text

The Full Text of this article is available as a PDF (825.9 KB).

References

  1. Adams HR. Veterinary Pharmacology and Therapeutics. Ames: Iowa State University Press; 1995. p. 1181. [Google Scholar]
  2. Anonymous: Case closed on pyrazolidones? Animal Pharm. 1997, 384, 3.
  3. Backer P, Braeckman R, Backere M. Bioavailability and pharmacokinetics of phenylbutazone in the cow. J. vet. Pharm. Therap. 1980;3:29–33. doi: 10.1111/j.1365-2885.1980.tb00476.x. [DOI] [Google Scholar]
  4. Bishop YM: The Veterinary Formulary. 3rd ed. The Pharmaceutical Press, London, 1996, 513 pp.
  5. Moreno Chavez J, Bickhardt K. Zum Nachweis von Gewebsläsionen nach intramuskulärer Injektion durch Bestimmung der Creatinkinase-Aktivität im Blutplasma. (Demonstration of lesions in tissue after intramuscular injection by determination of creatine kinase activity in blood plasma). Dtsch. tierärztl. Wschr. 1997;104:512–515. [PubMed] [Google Scholar]
  6. George MH, Morgan JD, Glock RD, Tatum JD, Schmidt GR, Sofas JN, Cowman GL, Smith GC. Injection-site lesions: incidence, tissue histology, collagen concentration, and muscle tenderness in beef rounds. J. Anim. Sci. 1995;73:3510–3518. doi: 10.2527/1995.73123510x. [DOI] [PubMed] [Google Scholar]
  7. Kern O: Lokalverträglichkeit von Arznei- und Arzneihilfstoffen bei intramuskulärer Injektion. (Local effects of intramuscular drug injections). Teil 1–3. Tierärztl. Umschau 1987, 42, 768–775, 912–916, 971–972.
  8. Kopcha M, Kaneene JB, Shea ME, Miller RA. Use of nonsteroidal anti-inflammatory drugs in food animal practice. J. Am. Vet. Med. Ass. 1992;12:1868–1872. [PubMed] [Google Scholar]
  9. Landuyt J, Delbeke FT, Debackere M. The intramuscular bioavailability of a phenylbutazone preparation in the horse J. vet. Pharm. Therap. 1993;16:494–500. doi: 10.1111/j.1365-2885.1993.tb00216.x. [DOI] [PubMed] [Google Scholar]
  10. Lefébre HP, Toutain P, Serthelon J, Lassourd V, Gardey L, Braun J. Pharmacokinetic variables and bioavailability from muscle of creatine kinase in cattle. Am. J. Vet. Res. 1994;55:487–493. [PubMed] [Google Scholar]
  11. Lefébvre HP, Laroute V, Braun JP, Lassourd V, Toutain PL. Non-invasive and quantitative evaluation of post-injection muscle damage by pharmacokinetic analysis of creatine kinase release. Vet. Res. 1996;27:343–361. [PubMed] [Google Scholar]
  12. Lefébvre HP, Braun V, Laroute V, Toutain PL: Evaluation and mechanisms of tolerance of locally administered drugs. J. vet Pharmacol. Therap. 1997, 20 (Suppl. 1) 320–322.
  13. Rasmussen F. Tissue damage at the injection site after intramuscular injection of drugs. Vet. Science Commun. 1978;2:173–182. doi: 10.1007/BF02291447. [DOI] [Google Scholar]
  14. Rasmussen F, Svendsen O. Tissue damage and concentration at the injection site after intramuscular injection of chemotherapeutics and vehicles in pigs. Res. Vet. Sci. 1976;20:55–60. doi: 10.1016/S0034-5288(18)33479-9. [DOI] [PubMed] [Google Scholar]
  15. Pyörälä S, Manner E, Kesti E, Sandholm M: Local tissue damage in cows after intramuscular injections of 8 different antimicrobial agents. Brief communication. Acta vet. Scand. 1994, 35, 107– 110. [DOI] [PMC free article] [PubMed]
  16. Radostits OM, Blood DC, Gay CC: Diseases of Large Animals. 8th ed. Baillière Tindall, London 1994, 1763 pp.
  17. Sullivan M, Snow DH. Factors affecting absorption of nonsteroidal anti-inflammatory agents in the horse. Vet. Rec. 1982;110:554–558. doi: 10.1136/vr.110.24.554. [DOI] [PubMed] [Google Scholar]
  18. Szasz G, Waldesström J, Gruber W. Creatine kinase in serum: 6. Inhibition by endogenous polyvalent cations, and effect of chelators on the activity and stability of some assay components. Clin. Chem. 1979;25:446–452. [PubMed] [Google Scholar]
  19. Toutain PL, Lassourd V, Costes G, Alvinerie M, Bret L, Lefébvre HP, Braun JP. A non-invasive and quantitative method for the study of tissue injury caused by intramuscular injection of drugs in horses. J. vet Pharmacol. Therap. 1995;18:226–235. doi: 10.1111/j.1365-2885.1995.tb00583.x. [DOI] [PubMed] [Google Scholar]

Articles from Acta Veterinaria Scandinavica are provided here courtesy of BMC

RESOURCES